Volume | 0.00 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | Mínimo Máximo |
||||||
Minimo del Dia |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
XBiotech Inc | 4XB | Tradegate | Acción Ordinaria |
Variación del Día (ptos.) | Variación del Día (%) | Último Precio | Hora | |
---|---|---|---|---|
0.00 | 0.00% | 4.80 | 05:55:34 |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
4.80 |
Operaciones | Volume Operado de la Acción | Volumen promedio | Rango 52 semanas |
---|---|---|---|
0 | 0.00 | - | 3.32 - 9.05 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
- | 0 | 4.80 € | EUR |
Noticias sobre XBiotech Inc 4XB
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
19/6/2024 | 14:31 | GlobeNewswire Inc. | Ergebnisse aus randomisierter, doppelt verblindeter.. |
18/6/2024 | 10:35 | GlobeNewswire Inc. | XBiotech Results from Randomized Double-Blinded Phase 1/2.. |
04/1/2024 | 17:09 | GlobeNewswire Inc. | XBiotech beginnt mit dem Bau der neuen F&E-Anlage auf seinem.. |
04/1/2024 | 08:00 | GlobeNewswire Inc. | XBiotech to Begin Constructing New R&D Facility on its.. |
14/11/2023 | 21:32 | GlobeNewswire Inc. | Le Dr Alan Kivitz prend la tête du programme Natrunix,.. |
14/11/2023 | 08:00 | GlobeNewswire Inc. | Dr. Alan Kivitz to Chair XBiotech’s Natrunix Program in.. |
27/9/2023 | 00:00 | GlobeNewswire Inc. | XBiotech annonce l'achèvement du recrutement dans son essai.. |
26/9/2023 | 08:00 | GlobeNewswire Inc. | XBiotech Announces Enrollment Completion of Phase I Clinical.. |
Histórico de Datos 4XB
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.00 | 6.00 | 4.68 | 4.99 | 632 | -1.20 | -20.00% |
1 Month | 7.55 | 7.55 | 4.68 | 6.20 | 1,050 | -2.75 | -36.42% |
3 Months | 7.40 | 9.05 | 4.68 | 6.91 | 715 | -2.60 | -35.14% |
6 Months | 3.60 | 9.05 | 3.52 | 5.73 | 693 | 1.20 | 33.33% |
1 Year | 4.62 | 9.05 | 3.32 | 5.32 | 643 | 0.18 | 3.90% |
3 Years | 4.62 | 9.05 | 3.32 | 5.32 | 643 | 0.18 | 3.90% |
5 Years | 4.62 | 9.05 | 3.32 | 5.32 | 643 | 0.18 | 3.90% |